Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 104,762 | 87,166 | 74,999 | 71,530 | 57,794 |
| Cost of Goods | 8,437 | 8,055 | 6,297 | 7,378 | 6,532 |
| Gross Profit | 96,325 | 79,111 | 68,702 | 64,152 | 51,262 |
| Operating Expenses | 159,386 | 157,212 | 136,274 | 162,804 | 113,914 |
| Operating Income | -62,624 | -78,046 | -67,275 | -98,274 | -62,120 |
| Interest Expense | 1,978 | 1,299 | 1,082 | 702 | 757 |
| Pre-tax Income | -64,602 | -79,345 | -68,357 | -98,976 | -62,877 |
| Income Tax | N/A | N/A | N/A | -325 | -678 |
| Net Income Continuous | -64,602 | -79,345 | -68,357 | -98,651 | -62,199 |
| Net Income | $-64,602 | $-79,345 | $-68,357 | $-98,651 | $-62,199 |
| EPS Basic Total Ops | -1.34 | -1.67 | -1.44 | -2.15 | -1.32 |
| EPS Basic Continuous Ops | -1.34 | -1.67 | -1.44 | -2.15 | -1.32 |
| EPS Diluted Total Ops | -1.34 | -1.67 | -1.44 | -2.15 | -1.32 |
| EPS Diluted Continuous Ops | -1.34 | -1.67 | -1.44 | -2.15 | -1.32 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.24 | -1.09 | -0.73 | -1.32 |
| EBITDA(a) | $-60,219 | $-75,084 | $-64,825 | $-96,080 | $-60,522 |